Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C3 | Q8NEB9 | 12/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | BRAF | P15056 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.32 |
| ▸ | MTOR | P42345 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1848383 | 0.91 | CYP2C9 (0.44) | PIK3C3CYP3A4CYP2C9BRAFCYP2C19 | |
| SCHEMBL1847659 | 0.82 | PIK3C3 (0.44) | PIK3C3CYP3A4CYP2C9BRAFCYP2C19 | |
| SCHEMBL1848361 | 0.82 | PIK3C3 (0.57) | PIK3C3BRAF | |
| SCHEMBL1847624 | 0.77 | CYP2C9 (0.42) | CYP3A4CYP2C9BRAFCYP2C19PIK3CA | |
| SCHEMBL1850142 | 0.76 | BRAF (0.48) | PIK3C3BRAF | |
| SCHEMBL1847455 | 0.76 | ROCK2 (0.38) | — | |
| SCHEMBL14143256 | 0.72 | MAPK14 (0.45) | — | |
| SCHEMBL1848442 | 0.71 | BRAF (0.53) | CYP3A4CYP2C9BRAF | |
| SCHEMBL1852286 | 0.71 | CYP2C9 (0.42) | CYP3A4CYP2C9BRAFCYP2C19 | |
| SCHEMBL1849145 | 0.70 | PDE10A (0.34) | CYP3A4CYP2C9BRAFCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2324008-B1 | 3,4-DIARYLPYRAZOLES AS PROTEIN KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES SRL (IT) | 2012-05-09 | — | — | EP | disclosed |